Oracle Corporation (ORCL) Up 6.5% — Is This My Chance to Get In Early?
Oracle Corporation (ORCL) is staging a forceful rebound this Tuesday, last changing hands at $126.95 on the NYSE. That is a $7.73 gain from the prior close of $119.22 and one of the strongest single-session advances among large-cap software names. The rally starts from a deeply discounted base. ORCL remains roughly 52.2% below its 52-week high of $265.62, set on November 3, 2025, exactly one year ago. Investors who stayed patient through that drawdown are seeing the first clear sign that the overhang weighing on the shares is lifting.
Volume is running well ahead of normal, with about 51.04 million shares traded against a 90-day average of roughly 33.09 million. That is more than 54% above typical turnover with the session still in progress, showing that buyers are committing real capital to the move.
Why Oracle Corporation Price is Moving Higher
The catalyst is relief. Oracle has now priced its $20 billion financing plan rather than leaving it as an open-ended announcement. The deal combines 86.2 million shares sold at $116 with $10 billion of bonds carrying coupons as high as 8.65%. It fills the company's stated financing cap through fiscal 2030. The shares had fallen sharply after the plan was first disclosed, as investors weighed dilution and the cost of borrowing. Now that the terms are fixed and the funding window is closed, that uncertainty is off the table. Baird analyst Rob Oliver said the financing was "exactly what they previewed," and the market agreed. With shares now trading near $127, buyers of the $116 equity offering are already sitting on a gain of more than 9%.
The move also rides a broader bid for AI-infrastructure names. CoreWeave (CRWV) gained 5.26%, AMD rose 5.34%, and Microsoft (MSFT) added 2.55% in the same market update. Oracle's strength stands out against its software peers, which shows how much of the move is specific to Oracle. Salesforce, Inc. (CRM) slipped 1.45% and Shopify Inc. (SHOP) dropped 6.49% on the day. Investors are separating Oracle's capital-intensive AI buildout story from the rest of the application software group.
The fundamentals behind that buildout are strong. Oracle's most recent quarterly report, released on September 10, delivered adjusted EPS of $1.92 against a $1.74 estimate. Revenue reached $19.35 billion, ahead of the $19.14 billion consensus and up about 30% year over year. Net income climbed to $4.68 billion from $2.93 billion a year earlier. The investment burden is real: Q1 free cash flow was negative $5.4 billion, compared with negative $362 million a year earlier. That gap is what made the financing necessary. With the capital now secured, the market can refocus on the revenue and earnings trajectory that spending is designed to accelerate.
What is the Oracle Corporation Rating - Should I Buy?
Weiss Ratings assigns ORCL a C rating. Current recommendation is Hold. The rating reflects a company with first-rate operating fundamentals whose stock has handed shareholders a rough ride over the past year. That tension is exactly what makes today's rebound worth watching.
The business itself scores at the top of the scale. The Excellent rating on the Growth Index is anchored by 29.61% revenue growth, a rare pace for a company with Oracle's installed base and decades of enterprise relationships. The latest quarter's roughly 30% top-line increase shows that the AI and cloud infrastructure push is converting into reported sales. The Excellent Efficiency Index rating is backed by a 41.19% ROE and a 26.35% profit margin. Those figures show Oracle still runs a high-margin software franchise even while pouring capital into data center capacity. A Good rating on the Solvency Index fits that picture. The balance sheet can carry the new $10 billion bond issue, though coupons as high as 8.65% and deeply negative free cash flow explain why solvency stops short of Excellent.
Where the picture becomes more nuanced is in the market-facing measures. The Weak rating on the Total Return Index reflects a stock still trading more than 52% below its $265.62 peak, a drawdown that erased a large share of shareholder value in twelve months. The same story explains the Weak Volatility Index. The sharp selloff on the financing announcement, followed by today's 6.48% relief rally once the deal was priced, is the kind of swing that keeps the rating from moving higher. The Dividend Index is rated Fair, consistent with a 1.68% yield that supports total return but is not the core of the investment case. At a forward P/E of 18.69 on trailing EPS of $6.38, valuation has compressed meaningfully for a company growing near 30%.
Within the Information Technology sector, Oracle sits alongside Salesforce, Inc. (CRM, C), Palo Alto Networks, Inc. (PANW, C), and CrowdStrike Holdings, Inc. (CRWD, C). International Business Machines Corporation (IBM, C+) holds a slight edge in Weiss's framework. Oracle's Excellent Growth and Efficiency readings, however, give it some of the strongest underlying fundamentals in that group.
About Oracle Corporation
Oracle Corporation (ORCL) is an Information Technology company and one of the foundational names in enterprise computing. Founded in 1977 and headquartered in Austin, Texas, Oracle built its franchise on Oracle Database, which remains the system of record for transaction processing at a large share of the world's largest corporations, banks, and government agencies. The database business now extends into the Autonomous Database and Exadata engineered systems, which pair Oracle's software with purpose-built hardware for high-performance workloads.
Oracle Cloud Infrastructure (OCI) is the centerpiece of the company's growth strategy. It provides compute, storage, and networking capacity that has become increasingly important for training and running artificial intelligence models, and that AI demand drives the heavy data center investment now underway. Alongside infrastructure, Oracle sells a broad suite of cloud applications. Fusion Cloud ERP serves large enterprises, NetSuite serves mid-sized businesses, and human capital management and supply chain software round out the portfolio. Oracle Health, built on the acquisition of Cerner, extends the company into electronic health records and clinical systems.
Oracle's competitive advantages come from deep incumbency in mission-critical enterprise data, high switching costs, and the ability to bundle database, infrastructure, and applications into a single vendor relationship. Its stewardship of Java and MySQL keeps it embedded in the developer ecosystem. Its multicloud partnerships allow Oracle Database to run inside rival cloud environments, widening its reach without ceding the customer relationship.
Investor Outlook
With the $20 billion financing priced and funding secured through fiscal 2030, Oracle (ORCL) has removed its largest near-term overhang. That shifts attention back to a business growing revenue near 30% at a forward P/E below 19. Investors should watch whether the next quarterly report shows cloud infrastructure revenue accelerating fast enough to narrow the negative $5.4 billion free cash flow gap, and whether the shares can hold above the $116 offering price as new supply is absorbed. See full rankings of all C-rated Information Technology stocks inside the Weiss Stock Screener.
--